These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27760891)

  • 1. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
    Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
    Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay.
    Takagi S; Miura J; Hoshina S; Uchigata Y; Babazono T
    J Diabetes Investig; 2020 Mar; 11(2):356-362. PubMed ID: 31267698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Autoimmune Thyroid Disease with Anti-GAD Antibody ELISA Test Positivity and Risk for Insulin Deficiency in Slowly Progressive Type 1 Diabetes.
    Katahira M; Ogata H; Ito T; Miwata T; Goto M; Nakamura S; Takashima H
    J Diabetes Res; 2018; 2018():1847430. PubMed ID: 30116734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
    PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes.
    Kawasaki E; Shimada A; Imagawa A; Abiru N; Awata T; Oikawa Y; Osawa H; Kawabata Y; Kozawa J; Kobayashi T; Takahashi K; Chujo D; Fukui T; Miura J; Yasuda K; Yasuda H; Kajio H; Hanafusa T; Ikegami H;
    J Diabetes Investig; 2023 Apr; 14(4):570-581. PubMed ID: 36691729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
    Kawasaki E; Awata T; Ikegami H; Imagawa A; Oikawa Y; Osawa H; Katsuki T; Kanatsuna N; Kawamura R; Kozawa J; Kodani N; Kobayashi T; Shimada A; Shimoda M; Takahashi K; Chujo D; Tsujimoto T; Tsuchiya K; Terakawa A; Terasaki J; Nagasawa K; Noso S; Fukui T; Horie I; Yasuda K; Yasuda H; Yanai H; Hanafusa T; Kajio H;
    J Diabetes Investig; 2024 Jul; 15(7):835-842. PubMed ID: 38451108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
    Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
    J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practice.
    Oikawa Y; Kondo T; Shimada A; Seino Y; Kitaoka M
    J Diabetes Investig; 2019 May; 10(3):685-689. PubMed ID: 30307126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
    Takehana N; Fukui T; Mori Y; Hiromura M; Terasaki M; Ohara M; Takada M; Tomoyasu M; Ito Y; Kobayashi T; Yamagishi SI
    J Diabetes Investig; 2023 Jul; 14(7):856-863. PubMed ID: 37082800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
    Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus.
    Kobayashi T; Maruyama T; Shimada A; Kasuga A; Kanatsuka A; Takei I; Tanaka S; Yokoyama J
    Ann N Y Acad Sci; 2002 Apr; 958():117-30. PubMed ID: 12021091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes.
    Kawasaki E; Shimada A; Imagawa A; Abiru N; Awata T; Oikawa Y; Osawa H; Kawabata Y; Kozawa J; Kobayashi T; Takahashi K; Chujo D; Fukui T; Miura J; Yasuda K; Yasuda H; Kajio H; Hanafusa T; Ikegami H;
    J Diabetes Investig; 2023 Jan; 14(1):58-66. PubMed ID: 36177861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
    Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating anti-glutamic acid decarboxylase-65 antibody titers are positively associated with the capacity of insulin secretion in acute-onset type 1 diabetes with short duration in a Japanese population.
    Yamamura S; Fukui T; Mori Y; Hayashi T; Yamamoto T; Ohara M; Fukase A; Sasamori H; Kobayashi T; Hirano T
    J Diabetes Investig; 2019 Nov; 10(6):1480-1489. PubMed ID: 30919585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
    Ota T; Takamura T; Nagai Y; Bando Y; Usuda R
    Diabetes Res Clin Pract; 2005 Jan; 67(1):63-9. PubMed ID: 15620435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM).
    Tanaka S; Okubo M; Nagasawa K; Takizawa S; Ichijo M; Ichijo S; Kaneshige M; Aida K; Shimura H; Mori Y; Kobayashi T
    Diabetol Int; 2016 Mar; 7(1):42-52. PubMed ID: 30603242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity among patients with latent autoimmune diabetes in adults.
    Maruyama T; Nakagawa T; Kasuga A; Murata M
    Diabetes Metab Res Rev; 2011 Nov; 27(8):971-4. PubMed ID: 22069295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.